10 March 2021

GSK Stockmann advises Union Investment on acquisition of Bochum Prime

GSK Stockmann has advised Union Investment Institutional Property GmbH on the acquisition of the Bochum Prime campus property from German-Irish investor Signature Capital. The property consists of a building dating from 1920 and five additional structures raised in 2005. The ensemble encompasses around 25,000 m² and is fully let on a long-term basis to BP Europe. The company uses the property as its German headquarters. The parties agreed to keep the purchase price confidential.

Union Investment has acquired the property for the Urban Campus Nr.1 special fund, which is launched jointly with Investa Capital Management (ICM). Bochum Prime is the sixth asset in the fund, following acquisitions in Fürth, Nuremberg, Constance, Mannheim and Munich. And as with all Urban Campus No. 1 properties, Investa Real Estate is in charge of portfolio and tenant management.

The campus property is located to the southeast of Bochum’s city centre, about 450 meters from the main train station. Mixed and residential areas can be found east and south of the property. The Kortumpark borders directly on the northern side of the building ensemble. As a result, the campus property promotes an urban lifestyle that combines working and living in the same location.

Union Investment and Investa were comprehensively advised by GSK Stockmann on real estate and tax law. Signature Capital was provided with legal advice by Lambsdorff Rechtsanwälte. Colliers International Deutschland GmbH, based in Düsseldorf, acted as intermediary.

Advisers of Union Investment:
GSK Stockmann: Michael Eggersberger (lead, Real Estate), Petra Eckl, Dominik Berka (Tax); Associates: Felix Bergfort (Real Estate), Kristina Marx (Public Law)

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 24 August 2021

    GSK Update: New marketing rules for investment management companies

    Read more
  • 23 June 2021

    GSK Update: The new German law on corporate due diligence in supply chains

    Read more
  • 21 June 2021

    GSK Update: Global data transfer: The new standard data protection clauses – What needs to be done?

    Read more
Contact person

Dr. Michael Eggersberger

Partner*

+49 69 710003-236

michael.eggersberger@gsk.de

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral